0 NYSE Companies - November 5, 2024Tejon Ranch Co. Announces Addition of Four Board MembersTEJON RANCH, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) — Tejon Ranch Co. (TRC: NYSE) is pleased to announce the election […]Read More
0 NYSE Companies - November 5, 2024Sprott Inc. Announces 20% Dividend Increase and Declares Third Quarter 2024 DividendTORONTO, Nov. 05, 2024 (GLOBE NEWSWIRE) — Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board […]Read More
0 TSX Venture News - November 5, 2024Pine Point Mining Limited and the Town of Hay River Sign MOUMONTREAL, Nov. 05, 2024 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: […]Read More
0 NYSE Companies - November 5, 2024Eastman Kodak Company Third – Quarter 2024 Earnings Conference CallRochester, N.Y., Nov. 05, 2024 (GLOBE NEWSWIRE) — Kodak will host the Third-Quarter 2024 Earnings call on Tuesday, November 12, […]Read More
0 NYSE Companies - November 5, 2024La-Z-Boy Incorporated Announces Timing of Fiscal 2025 Second Quarter Earnings Release and Conference CallMONROE, Mich., Nov. 05, 2024 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB) will report its Fiscal 2025 Second Quarter results […]Read More
0 NASDAQ Companies - November 5, 2024Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual MeetingSOUTH SAN FRANCISCO, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a […]Read More
0 NASDAQ Companies - November 5, 2024Crown Announces Suspension of Equity Line of CreditLOS ANGELES, Nov. 05, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading provider […]Read More
0 NASDAQ Companies - November 5, 2024Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross ProceedsMINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company […]Read More
0 TSX Venture News - November 5, 2024SAGA Metals Corp. Completes Second & Final Tranche of IPO Prospectus OfferingVANCOUVER, British Columbia, Nov. 05, 2024 (GLOBE NEWSWIRE) — SAGA Metals Corp. (TSXV: “SAGA”) (FSE: “20H”) (“SAGA” or the “Company”), […]Read More
0 NYSE Companies - November 5, 2024NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024CARMEL, Ind., Nov. 05, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology […]Read More